Prof. Ann Partridge, North American POSITIVE Study Chair, received this year’s ESMO Award during the ESMO Congress 2024 for her outstanding work on improving the treatment, survivorship and psychosocial issues facing young patients with breast cancer. Read her interview on the ESMO Daily Report.
“Our research has shown that a substantial proportion of young breast cancer survivors were so anxious about fertility that they were less likely to initiate endocrine therapy or were less adherent than young patients without fertility concerns (Cancer. 2021;127:2888–2894). This research culminated in the POSITIVE trial, which I consider to be the most important piece of work to which I have contributed (N Engl J Med. 2023;388:1645–1656). The study was a team effort, led by Olivia Pagani from Switzerland, through the International Breast Cancer Study Group.”
Donating & Supporting